Vittorio Gebbia
10.1159/000523856
Case Rep Oncol
2022 Mar 28;15(1):305-311.
abemaciclib end-stage renal disease estrogen receptor metastatic breast cancer
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/35529297/
Case Reports
PMC9035949
35529297
Abemaciclib in Patients with End-Stage Renal Disease and Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Report of 2 Cases
2022